Thanks Hopeful,
I'm always on the lookout for unicorns. I found Merrimack Pharma's pipeline and see they also have MM302 in the pipeline for advanced Her2 breast cancer:
MM-302 (Nanotherapeutic)
- Indication:
- Description:
- Target
- Advanced HER2+ breast cancer
- Antibody targeted nanotherapeutic
- HER2-targeted encapsulated doxorubicin
MM-302 is a HER2-targeted nanotherapeutic consisting of the chemotherapeutic doxorubicin, encapsulated in a liposomal sphere. Doxorubicin has been a standard therapy for the treatment of breast cancer for more than 30 years.
Doxorubicin is also known as Doxil, or Adriamycin.